Thomas Engleitner

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV

Alexey Stukalov, Virginie Girault, Vincent Grass et al. · Nature · 2021 · 715 citations · Full text

Proteomic Technology, Medicine, Multilevel Proteomics Reveals +6

Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry

Michal Bassani‐Sternberg, Eva Bräunlein, Richard Klar et al. · Nature Communications · 2016 · 698 citations · Full text

Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes

Sebastian Mueller, Thomas Engleitner, Roman Maresch et al. · Nature · 2018 · 431 citations · Full text

Pancreatic Cancer, Evolutionary Routes, Medicine +4

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Mohsen Malehmir, Dominik Pfister, Suchira Gallage et al. · Nature Medicine · 2019 · 360 citations · Full text

Hepatology, Medicine, Liver Physiology +9